Inventor
POLISETTI DHARMA RAO
US51 patents
⚠️ This page may combine multiple inventors who share the name “POLISETTI DHARMA RAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VTV THERAPEUTICS LLC
17 patentsUS10287284B2May 14, 2019
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC14 citations93
US9393245B2Jul 19, 2016
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC7 citations84
US10568888B2Feb 25, 2020
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC2 citations73
US10391097B2Aug 27, 2019
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC2 citations73
US11649230B2May 16, 2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC1 citations72
US11130753B2Sep 28, 2021
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10889580B2Jan 12, 2021
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10570126B2Feb 25, 2020
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10030011B2Jul 24, 2018
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US11524942B2Dec 13, 2022
Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine
VTV THERAPEUTICS LLC2 citations71
US10085990B2Oct 2, 2018
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC1 citations62
US9833457B2Dec 5, 2017
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC1 citations62
US9687489B2Jun 27, 2017
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC1 citations62
US11970457B2Apr 30, 2024
Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine
VTV THERAPEUTICS LLC0 citations60
US12545676B2Feb 10, 2026
Crystalline form of hydrochloride salt of quinoline derivative
VTV THERAPEUTICS LLC0 citations51
US12091407B2Sep 17, 2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC0 citations51
US10364233B2Jul 30, 2019
Piperidine derivative and methods of use thereof
VTV THERAPEUTICS LLC0 citations50
NOVO NORDISK AS
8 patentsUS7384967B2Jun 10, 2008
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS166 citations98
USRE45670ESep 15, 2015
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS34 citations97
US7541373B2Jun 2, 2009
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS123 citations97
US7598391B2Oct 6, 2009
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS14 citations92
US7897628B2Mar 1, 2011
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS15 citations91
USRE45183EOct 7, 2014
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS7 citations83
US7872139B2Jan 18, 2011
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS10 citations83
US7851636B2Dec 14, 2010
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS8 citations83
TRANSTECH PHARMA LLC
7 patentsUS8703766B2Apr 22, 2014
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA LLC6 citations83
US9120813B2Sep 1, 2015
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA LLC4 citations82
US9198901B2Dec 1, 2015
Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and pharmaceutical compositions and uses thereof
TRANSTECH PHARMA LLC4 citations68
US8933222B2Jan 13, 2015
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA LLC3 citations62
US9175003B2Nov 3, 2015
Substituted azoanthracene derivatives and intermediates for preparation thereof
TRANSTECH PHARMA LLC2 citations60
US8987295B2Mar 24, 2015
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
TRANSTECH PHARMA LLC3 citations60
US9162963B2Oct 20, 2015
Phenylglyoxylic acid derivatives and their preparation and use
TRANSTECH PHARMA LLC0 citations39
TRANSTECH PHARMA INC
5 patentsUS7812043B2Oct 12, 2010
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
TRANSTECH PHARMA INC93 citations97
US7906507B2Mar 15, 2011
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC12 citations92
US7727983B2Jun 1, 2010
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC11 citations92
US7790714B2Sep 7, 2010
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC10 citations83
US8383644B2Feb 26, 2013
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
TRANSTECH PHARMA INC3 citations60
MJALLI ADNAN M M
5 patentsUS8759535B2Jun 24, 2014
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
MJALLI ADNAN M M15 citations92
US8329715B2Dec 11, 2012
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
MJALLI ADNAN M M10 citations92
US8524708B2Sep 3, 2013
Oxadiazoanthracene compounds for the treatment of diabetes
MJALLI ADNAN M M6 citations83
US8450354B2May 28, 2013
Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors
MJALLI ADNAN M M7 citations71
US8853226B2Oct 7, 2014
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
MJALLI ADNAN M M1 citations62
POLISETTI DHARMA RAO
3 patentsUS8063081B2Nov 22, 2011
Aryl carbonyl derivatives as therapeutic agents
POLISETTI DHARMA RAO6 citations70
US8513430B2Aug 20, 2013
Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
POLISETTI DHARMA RAO0 citations50
US8927549B2Jan 6, 2015
Adamantyl benzamide derivatives
POLISETTI DHARMA RAO0 citations49
HIGH POINT PHARMACEUTICALS LLC
3 patentsUS9163022B2Oct 20, 2015
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
HIGH POINT PHARMACEUTICALS LLC1 citations62
US7964608B2Jun 21, 2011
Tricyclic compounds as modulators of TNF-α synthesis
HIGH POINT PHARMACEUTICALS LLC1 citations59
US8350039B2Jan 8, 2013
Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
HIGH POINT PHARMACEUTICALS LLC0 citations50
MURRAY ANTHONY
1 patentLAU JESPER
1 patentShowing the top 50 of 51 patents by PatentIndex Score.